Valyu Add is a free weekly research briefing for builders, investors and operators. Every issue is sourced, cited and verified with Valyu DeepResearch.
Your next cited briefing is on its way to .
GLP-1s like Ozempic began as a fleeting gut hormone. It became a drug class that changed diabetes care, weight loss, pharma economics, and the politics of hunger.
“Evidence first. One company or market at a time, with the sources close enough that a reader can verify the argument without starting from scratch.”
Structured research on companies, businesses and markets. Every claim cited, every trail reusable.
Free, weekly. One company or market, taken apart with sources attached.
Your next cited briefing is on its way to .
